Medicine
Daytrana 10 mg/9 hours transdermal patch
Daytrana 10 mg/9 hours transdermal patch is a prescription medicine containing Methylphenidate for transdermal use, marketed by Noven Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not store transdermal systems in refrigerators or freezers. Store at 25° C…
Key facts
- Active ingredient (INN)
- Methylphenidate
- Brand
- Daytrana
- Strength
- 10 mg/9 hours
- Dosage form
- Transdermal patch
- Route
- Transdermal
- Packs
- 30 patches
- Marketing authorisation holder
- Noven Therapeutics
- Manufacturer
- Noven Therapeutics
- Origin register
- US FDA, United States
- Storage
- Do not store transdermal systems in refrigerators or freezers. Store at 25° C (77° F), excursions permitted to 15-30° C (59-86° F). Do not store transdermal systems unpouched.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Schedule CII
- ATC code
- N06BA04 Methylphenidate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 April 2006
- Identifiers
- RxCUI 753436, 753437, 753438 +5DailyMed set ID 2c312c31-3198-4775-91ab-294e0b4b9e7fNDC 68968-5552Application NDA021514
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 patch in 1 carton / 9 h in 1 patch | 68968-5552-3 | Noven Therapeutics | 6 April 2006 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Methylphenidate
Clinical summary
Methylphenidate is a central nervous system stimulant indicated for the treatment of attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults, among other approved uses. MedsAcross supplies Methylphenidate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MethylphenidateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ritalin prescribing information (Sandoz) · U.S. National Library of Medicine, DailyMed
- Tuzulby: European public assessment report (EPAR) · European Medicines Agency
Need Daytrana 10 mg/9 hours transdermal patch for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.